
Elite Pharmaceuticals Inc Investor Relations Material
Latest events

Q3 2025
Elite Pharmaceuticals Inc
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Elite Pharmaceuticals Inc
Access all reports
Elite Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development, manufacture, and distribution of niche generic and oral controlled-release medications. The company primarily targets the opioid abuse-deterrent and extended-release segments of the pharmaceutical market, offering treatments across a variety of therapeutic areas. Elite Pharmaceuticals specializes in developing formulations that address controlled substance regulations and the potential for abuse. The company’s business model includes both the commercialization of its own products and contract manufacturing services for third-party pharmaceutical companies. The company is headquartered in Northvale, New Jersey, and its shares are listed on the OTCQB.
Latest articles
)
Upcoming IPOs to Watch in 2025
Potential IPOs in 2025 include prominent names like Shein, Databricks, Klarna, eToro, and Figma, to name a few. Let's take a closer look.
23 May 2025
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
Ticker symbol
ELTP
Country
🇺🇸 United States